Recombinant human interferon alfa 2A: gịnị ka ọ bụ maka na otu esi ewe ya

Ndinaya

• Olee otú iji
• 1. Hai cell na-arịa leukemia
• 2. Otutu myeloma
• 3. Non-Hodgkin si lymphoma
• 4. Adịghị ala ala myeloid leukemia
• 5. Ọrịa ịba ọcha n'anya B
• 6. nnukwu na-adịghị ala ala ịba ọcha n'anya C
• 7. Condylomata acuminata
• Onye na-ekwesịghị iji
• Omume puru omume

Recombinant mmadụ interferon alpha 2a bụ protein egosiri maka ọgwụgwọ nke ọrịa dịka ntutu leukemia ntutu, otutu myeloma, lymphoma na-abụghị Hodgkin, ọrịa myeloid na-adịghị ala ala, ịba ọcha n'anya B, nnukwu ịba ọcha n'anya C na acuminate condyloma.

A na-eche na ọgwụ a ga-arụ ọrụ site na igbochi imegharị nje na ịmegharị nzaghachi nke onye nnabata ahụ, si otú a na-egosipụta antitumor na ọrụ antiviral.

Olee otú iji

Recombinant human interferon alfa 2A kwesiri ịhazi onye ọkachamara ahụike, onye ga-ama otu esi akwadebe ọgwụ. Usoro onyonyo dabere na ọrịa a ga-emeso ya:

1. Hai cell na-arịa leukemia

Bọchị ọgwụ a na-atụ aro ya bụ 3 MIU maka izu 16 ruo 20, nke a na-enye dị ka intramuscular ma ọ bụ subcutaneous injection. Ọ nwere ike ịdị mkpa iji belata ọgwụ ma ọ bụ ugboro ole injections iji chọpụta ọgwụ kachasị anabata. Nlekọta mmezi a kwadoro bụ 3 MIU, ugboro atọ n'izu.

Mgbe mmetụta dị oke njọ, ọ nwere ike ịdị mkpa iji belata ọgwụ ahụ na ọkara ma dọkịta ga-ekpebi ma onye ahụ kwesịrị ịga n'ihu ọgwụgwọ mgbe ọnwa isii gachara.

2. Otutu myeloma

Kpụrụ a na-atụ aro nke mmadụ interferon alfa 2A bụ 3 MIU, ugboro atọ n'izu, ka a na-enye dị ka intramuscular ma ọ bụ subcutaneous injection. Dịka nzaghachi na nnabata onye ahụ, enwere ike iji nwayọ nwayọ ruo 9 MIU, ugboro atọ n'izu.

3. Non-Hodgkin si lymphoma

N'ebe ndị mmadụ nwere lymphoma na-abụghị Hodgkin, enwere ike ịnye ọgwụ ahụ ruo izu 4 ruo 6 mgbe chemotherapy na ọgwụ a tụrụ aro bụ 3 MIU, ugboro atọ n'izu maka opekata mpe izu iri na abụọ, n'okpuru ụzọ. Mgbe a na-ejikọ ya na ọgwụ ọgwụ, usoro a tụrụ aro bụ 6 MIU / m2, na-edozi ya n'okpuru ma ọ bụ intramuscularly n'oge ụbọchị 22 ruo 26 nke chemotherapy.

4. Adịghị ala ala myeloid leukemia

A na-eji nwayọọ nwayọọ mụbaa ọgwụ nke mmadụ interferon alfa 2A na-arịwanye elu site na 3 MIU kwa ụbọchị ruo ụbọchị atọ ruo 6 MIU kwa ụbọchị ruo ụbọchị atọ nke 9 MIU kwa ụbọchị ruo mgbe ngwụcha nke usoro ọgwụgwọ ahụ. Mgbe izu 8 ruo 12 nke ọgwụgwọ, ndị ọrịa nwere nzaghachi haematological nwere ike ịga n'ihu ọgwụgwọ ruo mgbe nzaghachi zuru oke ma ọ bụ ọnwa 18 ruo afọ 2 mgbe ịmalitechara ọgwụgwọ.

5. Ọrịa ịba ọcha n'anya B

Kpụrụ a tụrụ aro maka ndị okenye bụ 5 MIU, ugboro atọ n'izu, na-edozi ya n'ụzọ dị n'okpuru ọnwa 6. Maka ndị mmadụ na-anaghị anabata refebinant interferon alpha 2A mgbe otu ọnwa gwọchara ya, mmụba nke ọgwụ nwere ike ịdị mkpa.

Ọ bụrụ, mgbe ọnwa 3 gachara ọgwụgwọ, enweghị nzaghachi sitere n'aka onye ọrịa ahụ, a ga-atụle ịkwụsị ọgwụgwọ.

6. nnukwu na-adịghị ala ala ịba ọcha n'anya C

Kpụrụ a tụrụ aro nke mmadụ interferon alfa 2A maka ọgwụgwọ bụ 3 ka 5 MIU, ugboro atọ n'izu, na-edozi ya n'okpuru ma ọ bụ intramuscularly maka ọnwa 3. Nlekọta mmezi a kwadoro bụ 3 MIU, ugboro atọ n'izu maka ọnwa 3.

7. Condylomata acuminata

Ngwadogwu akwadoro bụ subcutaneous ma ọ bụ intramuscular ngwa nke 1 MIU na 3 MIU, 3 ugboro n'izu, maka 1 ka ọnwa 2 ma ọ bụ 1 MIU etinyere na ntọala nke saịtị ahụ metụtara na ụbọchị ndị ọzọ, maka izu 3.

Onye na-ekwesịghị iji

E kwesịghị iji ọgwụ a mee ihe na ndị na-eme ka ihe ọ bụla nke ihe ndị dị na usoro ahụ, na-arịa ọrịa ma ọ bụ akụkọ ihe mere eme nke obi siri ike, akụrụ ma ọ bụ ọrịa imeju.

Na mgbakwunye, ekwesighi ka ejiri ya na ụmụ nwanyị dị ime ma ọ bụ na-enye nwa ara, belụsọ na dọkịta gwara ya.

Omume puru omume

Mmetụta ndị kachasị emetụta nke nwere ike ime na iji ọgwụ a bụ ihe mgbaàmà dịka flu, dị ka ike ọgwụgwụ, ahụ ọkụ, ahụ ọkụ, mgbu mgbu, isi ọwụwa, mgbu nkwonkwo, ọsụsọ, na ndị ọzọ.